Analysts at CIBC Capital Markets are intrigued by the development of cannabis beverages in Canada, while keeping an eye on the US legal landscape.

In a new note evaluating the Q2 time period for the cannabis sector, John Zamparo, cannabis analyst at the firm, said cannabis-derived beverages are poised to “capture a meaningful amount of new consumers, while margins are attractive, and above that of dried flower for most producers.”


However, in order for this projection to come true, distribution needs to significantly expand.

The promise of cannabis beverages has gone through highs and lows, and the drinks have been hailed by some as a promising new arena for the legalized cannabis industry.

But in his note, Zamparo indicates that these drinks will need distribution points such as “liquor stores or even on-premise consumption at bars or restaurants.” Until then, he sees beverages remaining a niche product for Canadian consumers, stuck at just a 5 percent share of retail sales.

Based on an independent survey of cannabis retailers, the analyst found that beverage offerings from Canopy Growth (NYSE:CGC,TSX:WEED) dominate both in availability and in terms of sales by way of the conpany’s Houseplant Grapefruit drink.

In terms of its actual ratings, CIBC continues to favor Canopy Rivers (TSX:RIV,OTC Pink:CNPOF) and Cronos Group (NASDAQ:CRON,TSX:CRON) as outperformers.

Aphria (NYSE:APHA,TSX:APHA), Aurora Cannabis (NYSE:ACB,TSX:ACB), Canopy Growth and Organigram Holdings (NASDAQ:OGI,TSX:OGI) all received neutral ratings, while Sundial Growers (NASDAQ:SNDL) and HEXO (NYSE:HEXO,TSX:HEXO) are seen as underperformers at the moment.

US update from a Canadian perspective

When it comes to US federal cannabis legalization or reform of some kind, Zamparo seems encouraged by projections for a Joe Biden presidency alongside a Democrat-led Senate.

If any significant policy moves ahead in the wake of a potential Biden victory, Zamparo believes Aphria, Canopy Growth, Canopy Rivers and Cronos Group have the best outlooks for an entry into the US.

“Most importantly, all four have strong balance sheets with capital to invest, while also communicating that, under the right legal conditions, America would be a target for their M&A prospects,” he said.

Zamparo also said the economic effects of the novel coronavirus in the US could have an unexpected positive side effect for the cannabis industry.

The analyst now expects to see a shift in legalization policy from state governors who feel the need to create revenue for their jurisdictions amid the pandemic.

“We suspect that several states that are legal for medical-use, such as Pennsylvania, New Jersey and Arizona, could be the next jurisdictions to move towards adult-use,” Zamparo wrote.

Parting shot highlights future deals

In the note, Zamparo also highlights the status of Canopy Growth’s acquisition deal for US multi-state operator (MSO) Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF).

The two firms are evaluating new terms for the agreement, and in the eyes of CIBC these favor Canopy Growth and its holders entirely.

The analyst called these changes in the transaction an “unambiguous win for Canopy.” They include: a lower purchase price, a percentage ownership mandate reduction from 100 to 70 percent, an extended deadline to 2030 and increased hemp operation capabilities in the US market.

“We believe ACRG has little to no leverage, and so we expect the proposed amendments to pass,” Zamparo wrote.

Things have changed drastically from the unveiling of the union in April 2019. At the time, Canopy Growth and Acreage confirmed an acquisition plan in which the Canadian giant would incorporate the MSO as its US partner; additionally, Acreage would get access to brand research from Canopy.

The CIBC report also notes that investors should keep a close eye on EBITDA developments seen in the space, as smaller players like Delta 9 Cannabis (TSX:DN,OTCQX:VRNDF) and Aleafia Health (TSX:AH,OTCQX:ALEAF) have reached EBITDA profitability.

“We deem it extremely unlikely that the industry’s producers will meet consolidated consensus EBITDA estimates next year, but we expect a greater number of EBITDA-positive business a year from now,” the report states.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less